Obtaining medication without proper supervisionfrom multiple doctors, online sources, or using someone else's prescriptioncrosses important safety boundaries
It may be that we should continue treatment in people who have had cardiovascular disease, even if they dont lose as much weight as we would like. This is already the case in the United States where, in March 2024, the US Food and Drug Administration approved Wegovy to treat adults with cardiovascular disease who also have obesity or are overweight but without diabetes mellitus
Low et al., 2001)
doi: 10.1016/j.febslet.2007.11.057
High-protein, portion-controlled meals developed with registered dietitian input for Ozempic, Wegovy, and Mounjaro users
W kontekcie tego problemu szczegln uwag naukowcw przyciga Tripeptide-41 , ktry stymuluje lipoliz, czyli proces rozkadu tuszczw